CAS: 1838651-58-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-[1-[(5-氰基-2-吡啶基)甲基]-1H-吡唑-3-基]-4-[1-(三氟甲基)环丙基]苯乙酰胺 REF: IN-DA01FW7ZCAS: 1838651-58-3 | 98% | 171.00 €~289.00 € | Tue 15 Oct 24 |
 | ACT-709478 REF: TM-T14120CAS: 1838651-58-3 | - - - | 70.00 €~173.00 € | Fri 18 Oct 24 |
 | ACT-709478 REF: 3D-NYC65158CAS: 1838651-58-3 | Min. 95% | To inquire | Tue 26 Nov 24 |
![N-[1-[(5-氰基-2-吡啶基)甲基]-1H-吡唑-3-基]-4-[1-(三氟甲基)环丙基]苯乙酰胺](https://static.cymitquimica.com/products/IN/thumb/DA01FW7Z.jpg)
N-[1-[(5-氰基-2-吡啶基)甲基]-1H-吡唑-3-基]-4-[1-(三氟甲基)环丙基]苯乙酰胺
CAS:1838651-58-3
Formula:
C22H18F3N5O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
425.4064
Ref: IN-DA01FW7Z
| 5mg | 171.00 € | ||
| 10mg | 289.00 € |
Estimated delivery in United States, on Tuesday 15 Oct 2024
ACT-709478
CAS:1838651-58-3
ACT-709478: potent, selective oral T-type calcium blocker, brain-penetrant, for generalized epilepsy research.
Formula:
C22H18F3N5O
Color and Shape:
Solid
Molecular weight:
425.41
Ref: TM-T14120
| 2mg | 95.00 € | ||
| 5mg | 173.00 € |
Estimated delivery in United States, on Friday 18 Oct 2024
ACT-709478
CAS:1838651-58-3
ACT-709478 is an orally bioavailable, non-peptide small molecule for the treatment of epileptic patients. It …
Formula:
C22H18F3N5O
Purity:
Min. 95%
Molecular weight:
425.4 g/mol
Ref: 3D-NYC65158
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
